Attitudes of European psychiatrists on psychedelics: a qualitative study.
Frontiers in psychiatry January 1, 2024 Marija Franka Žuljević, Nando Breški, Mariano Kaliterna et al. 6 citations
Psychiatrists in Europe who are not involved in psychedelic research see both promise and risk in psychedelic-assisted psychotherapy (PAP). Based on interviews with 12 specialists and trainees from 8 countries, four themes emerged: psychedelics hold potential, they are dangerous, their future is uncertain, and psychiatry is ambivalent toward them. Respondents acknowledged PAP's potential but considered its evidence base not yet robust enough. They reported that education on psychedelics is lacking in medical and psychiatric training and should be improved to help mental health experts participate in decisions about PAP.